As for diseases requiring anti-VEGF treatment, false prediction was noted in cases with borderline disease activity or other retinal disorders, such as central serous chorioretinopathy and epiretinal membrane, for which anti-VEGF treatment is not indicated. The gene discussed is VEGFA; the disease is retinal disorder.